parp inhibitors as first-line maintenance therapy in ovarian cancer
Published 2 years ago • 310 plays • Length 59:02Download video MP4
Download video MP3
Similar videos
-
35:35
maximizing the potential of parp inhibitors as first-line maintenance therapy in ovarian cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
1:26
parp inhibitors for maintenance therapy in ovarian cancer
-
58:46
learn all about parp inhibitors with dr jon krell, consultant medical oncologist
-
19:09
ecco 2017 - a new parp inhibitor to clinical practice - part 4
-
1:03:39
precision medicine in ovarian cancer with parp inhibitor therapy and companion diagnostics
-
9:47
can parp inhibitors offer benefit for all patients with platinum-sensitive ovarian cancer?
-
17:22
ecco 2017 - a new parp inhibitor to clinical practice - part 2
-
4:17
maintenance therapy in ovarian cancer: parp inhibitors
-
58:12
enhancing personalized medicine in ovarian cancer: advances in parp inhibition and novel modalities
-
2:15:30
ovarian cancer symposium 2021: session 4 parp inhibitors
-
24:56
gynecologic cancer education: parp inhibitor therapy
-
6:20
parp inhibitors in recurrent ovarian cancer
-
34:17
parp inhibitors for the treatment of ovarian cancer - gottfried konecny, md | uclamdchat
-
3:45
parp inhibitors for ovarian cancer
-
4:12
parp inhibitors
-
10:11
emerging treatment options for platinum-sensitive ovarian cancer
-
1:00:06
webinar: parp inhibitors and ovarian cancer
-
4:40
solo-1 and parp inhibitors in ovarian cancer